SCHEMBL25809038

SCHEMBL25809038

C=C/C(=C\C=C/C)S(=O)(=O)NC(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27311271 0.78 — —
SCHEMBL25808865 0.72 — —
SCHEMBL10331502 0.71 — —
SCHEMBL22193153 0.71 — —
SCHEMBL16867389 0.71 — —
SCHEMBL28321151 0.70 — —
SCHEMBL8367430 0.70 — —
SCHEMBL21014440 0.68 — —
SCHEMBL24930780 0.66 — —
SCHEMBL17612637 0.66 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023114366-A2 SULFONAMIDE DERIVATIVES AND THEIR USE AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2023-06-22 — — WO disclosed
Send feedback